Product image of Meropenem Steriscience (Meropenem) supplied by GNH India

Meropenem Steriscience

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Steriscience (Meropenem)

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as a sterile injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, severe pneumonia, sepsis and septic shock in hospitalized patients.

GNH India supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Steriscience B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

  • Complicated intra‑abdominal infections: effective for treating severe intra‑abdominal infections caused by susceptible organisms.
  • Complicated urinary tract infections: clears resistant Gram‑negative uropathogens in hospitalized patients.
  • Bacterial meningitis: achieves therapeutic concentrations in cerebrospinal fluid for meningitis caused by susceptible bacteria.
  • Severe community‑acquired or nosocomial pneumonia: provides coverage against multidrug‑resistant respiratory pathogens.
  • Sepsis and septic shock: rapid bactericidal activity helps control systemic infections in critical care settings.

How It Works

  • Meropenem binds to penicillin‑binding proteins (PBPs) on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and bacterial death. Its high affinity for a broad range of PBPs gives it activity against many Gram‑negative, Gram‑positive and anaerobic organisms, including many resistant strains.

Side Effects

Adverse reactions may occur with any antimicrobial therapy and should be monitored during treatment.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limited.
  • Rash: erythematous skin eruptions.
  • Headache: transient cranial discomfort.
  • Elevated liver enzymes: mild transaminase increases.
  • Injection‑site phlebitis: local irritation at IV site.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disease.
  • Clostridioides difficile infection: severe colitis risk.
  • Anaphylaxis: acute hypersensitivity reaction.
  • Severe neutropenia: marked reduction in white blood cells.
  • Renal toxicity: acute kidney injury in susceptible individuals.

Precautions & Warnings

Use meropenem with caution and observe clinical monitoring for potential complications.

  • Renal impairment: adjust dose based on creatinine clearance.
  • Hypersensitivity: discontinue if allergic reactions develop.
  • Pregnancy: only if clearly needed, as safety data are limited.
  • Seizure risk: avoid in patients with a history of epilepsy or CNS disorders.
  • Concomitant nephrotoxic drugs: monitor renal function closely.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Valproic acid: carbapenems can reduce valproate levels, risking seizure breakthrough.
  • Probenecid: may increase meropenem plasma concentrations, enhancing toxicity.
  • Carbapenem‑anticonvulsant interaction: increased seizure risk when combined with other seizure‑lowering agents.

Moderate Interactions (Monitor Closely)

  • Aminoglycosides: additive nephrotoxicity; monitor renal function.
  • Loop diuretics: may exacerbate renal impairment.
  • NSAIDs: potential for reduced renal clearance; observe kidney markers.

Frequently Asked Questions

Meropenem Steriscience is indicated for serious bacterial infections that require intravenous therapy, including complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, severe community‑acquired or nosocomial pneumonia, and sepsis or septic shock caused by susceptible organisms.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, weakening the wall and causing osmotic lysis of the bacterium, resulting in rapid bactericidal activity against a broad spectrum of Gram‑negative, Gram‑positive and anaerobic pathogens.

The specific dose and infusion rate of Meropenem Steriscience are determined by the prescribing clinician based on the infection type, severity, patient weight, renal function and local susceptibility patterns. Healthcare professionals should follow institutional protocols and product labeling when prescribing.

Safety data for Meropenem in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Meropenem offers a broader spectrum against many resistant Gram‑negative organisms and has a lower propensity for inducing seizures compared with imipenem‑cilastatin. Both are administered intravenously, but dosing intervals and renal adjustment differ, so clinicians select the agent based on pathogen susceptibility, patient renal function and safety profile.

Meropenem Steriscience must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Before use, inspect the vial for particulate matter and ensure the solution is at room temperature if required for infusion, following aseptic technique.

The product is supplied as a sterile powder for reconstitution. After reconstitution with the appropriate diluent, it is administered by intravenous infusion over 15‑30 minutes, or as a prolonged infusion depending on the clinical protocol and patient renal function.

The most serious adverse events include seizures, especially in patients with renal dysfunction or pre‑existing CNS disease, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant neutropenia or renal toxicity that require immediate medical attention.

Meropenem is contraindicated in patients with a known hypersensitivity to meropenem, other carbapenems, or any component of the formulation. Caution is also advised for individuals with a history of seizures, severe renal impairment not appropriately dose‑adjusted, or those receiving valproic acid without alternative seizure control.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT